Anonymous (2026). Efficacy and safety of a novel size-adjustable cryoballoon versus conventional cryoballoon: Results from the CONTRAST-CRYO II randomized clinical trial.. Heart rhythm.
Anonymous. Efficacy and safety of a novel size-adjustable cryoballoon versus conventional cryoballoon: Results from the CONTRAST-CRYO II randomized clinical trial.. Heart rhythm. 2026; PMID: 42203054
Anonymous. Efficacy and safety of a novel size-adjustable cryoballoon versus conventional cryoballoon: Results from the CONTRAST-CRYO II randomized clinical trial.[J]. Heart rhythm. 2026.
@article{paper2026,
author = {Anonymous},
title = {Efficacy and safety of a novel size-adjustable cryoballoon versus conventional cryoballoon: Results from the CONTRAST-CRYO II randomized clinical trial.},
journal = {Heart rhythm},
year = {2026},
note = {PMID: 42203054},
}
TY - JOUR AU - Anonymous TI - Efficacy and safety of a novel size-adjustable cryoballoon versus conventional cryoballoon: Results from the CONTRAST-CRYO II randomized clinical trial. T2 - Heart rhythm PY - 2026 AN - PMID:42203054 ER -
A size-adjustable cryoballoon (SACB, POLARxFIT), switching between 28-mm and 31-mm diameters, was introduced for atrial fibrillation (AF) ablation; however, its efficacy and safety compared with conventional cryoballoons (CCB, Arctic Front Advance) remain unknown.